Analysis of Measles-Mumps-Rubella (MMR) Titers of Recovered COVID-19 Patients

mBio - Tập 11 Số 6 - 2020
Jeffrey Gold1, William H. Baumgartl2, Ramazan Azim Okyay3, Warren E. Licht4, Paul L. Fidel5, Mairi C. Noverr6, Larry P. Tilley7, David J. Hurley8, Balázs Rada8, J. Wesson Ashford9
1World Organization, Watkinsville, Georgia, USA
2Nevada Spine Center, Las Vegas, Nevada, USA
3Kahramanmaraş Sütçü İmam University, Kahramanmaraş, Turkey
4Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA
5Louisiana State University Health Sciences Center, New Orleans, Louisiana, USA
6Tulane University School of Medicine, New Orleans, Louisiana, USA
7VetMed Consultants, Inc., Santa Fe, New Mexico, USA
8College of Veterinary Medicine, University of Georgia, Athens, Georgia, USA
9Stanford University, Stanford, California, USA

Tóm tắt

COVID-19 has presented various paradoxes that, if understood better, may provide clues to controlling the pandemic, even before a COVID-19 vaccine is widely available. First, young children are largely spared from severe disease. Second, numerous countries have COVID-19 death rates that are as low as 1% of the death rates of other countries. Third, many people, despite prolonged close contact with someone who is COVID-19 positive, never test positive themselves. Fourth, nearly half of people who test positive for COVID-19 are asymptomatic. Some researchers have theorized that the measles-mumps-rubella (MMR) vaccine may be responsible for these disparities. The significance of our study is that it showed that mumps titers related to the MMR II vaccine are significantly and inversely correlated with the severity of COVID-19-related symptoms, supporting the theorized association between the MMR vaccine and COVID-19 severity.

Từ khóa


Tài liệu tham khảo

10.3389/fmolb.2020.00120

10.1080/21645515.2020.1773141

10.1080/14787210.2020.1782742

10.1016/j.mehy.2020.109849

Pawlowski C Puranik A Bandi H Venkatakrishnan AJ Agarwal V Kennedy R O’Horo JC Gorres GJ Williams AW Halamka J Badley AD Soundararajan V. 2020. Exploratory analysis of immunization records highlights decreased SARS-CoV-2 rates in individuals with recent non-COVID-19 vaccinations. MedRxiv doi:10.1101/2020.07.27.20161976.

Gold J Tilley L Baumgartl W. 2020. MMR vaccine appears to confer strong protection from COVID-19: few deaths from SARS-CoV-2 in highly vaccinated populations. ResearchGate https://www.researchgate.net/publication/341354165_MMR_Vaccine_Appears_to_Confer_Strong_Protection_from_COVID-19_Few_Deaths_from_SARS-CoV-2_in_Highly_Vaccinated_Populations.

10.1016/j.vaccine.2012.08.057

10.1097/00000441-198003000-00002

CDC. 2019. Measles mumps and rubella (MMR) vaccination: what everyone should know. https://www.cdc.gov/vaccines/vpd/mmr/public/index.html.

10.1126/science.aay6485

10.1086/528993

10.1016/j.vaccine.2017.12.075

Franklin R Young A Neumann B Fernandez R Joannides A Reyahi A Modis Y. 2020. Homologous protein domains in SARS-CoV-2 and measles mumps and rubella viruses: preliminary evidence that MMR vaccine might provide protection against COVID-19. MedRxiv doi:10.1101/2020.04.10.2005320.

10.1016/j.vaccine.2019.05.056

10.1542/peds.2020-0702

10.1128/jcm.40.5.1733-1738.2002

10.2165/00003495-200363190-00012

10.1016/S0264-410X(00)00392-3

10.1126/science.aaa0698

10.1016/j.amjmed.2008.08.019

10.1126/science.aaf1098

10.1159/000355628

10.1186/s12889-015-1497-8

10.1093/jpids/piy142

10.1016/j.cell.2019.05.024

10.1038/s41577-020-0285-6

10.4049/jimmunol.174.2.767

10.3389/fimmu.2017.00832

10.1038/jhg.2008.5

10.1002/rmv.2135

10.1056/NEJMe2018629

10.1038/s41577-020-0337-y

10.1128/mBio.00907-20

10.1186/s13063-015-0651-z

Thông tin
Thông tin xuất bản

mBio

Tập 11 Số 6

Thông tin tác giả